Vascular endothelial growth factor: A possible mediator of endothelial activation in acute respiratory distress syndrome

Minerva Anestesiologica

Volumn 76, Issue 8, 2010, Pages 609-616

  Azamfirei, L ^a   Gurzu, S ^a   Solomon, R ^b   Copotoiu, R ^a   Copotoiu, S ^a   Jung, I ^a   Tilinca, M ^a   Branzaniuc, K ^a   Corneci, D ^c   Szederjesi, J ^a   Kovacs, J ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

ARDS; Endothelium; Lung; Vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MARKER; VASCULOTROPIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; AUTOPSY; BLOOD SAMPLING; CAUSE OF DEATH; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MALE; MEDIATOR RELEASE; OPEN LUNG BIOPSY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVOR; TISSUE LEVEL; UPREGULATION;

ADULT; AGED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954989662     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Chiumello D, Valente Barbas CS, Pelosi P. Pathophysiology of ARDS. In: Lucangelo U, Pelosi P, Zin WA, Aliverti A, editors. Respiratory system and artificial ventilation. Milan: Springer; 2008. p. 101-17
2. Cavaliere F, Mascia L, Terragni P. Year in Review in Minerva Anestesiologica, 2008. Minerva Anestesiol 2009;75:163-7.
3. Chiumello D, Caironi P, Colombo R, Grasso S. Year in review in Minerva Anestesiologica, 2007. I Critical Care. Experimental and clinical studies. Minerva Anestesiol 2008;74:35-40.
4. Chiumello D, Caironi P, Colombo R, Grasso S, Gattinoni L. A year in review in Minerva Anestesiologica, 2008. I Critical Care. Experimental and clinical studies. Minerva Anestesiol 2009;75:47-57.
5. Medford AR, Millar AB. Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax 2006;61:621-6.
6. Zhai R, Gong MN, Zhou W, Thompson TB, Kraft P, Su L et al. Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS. Thorax 2007;62:718-22.
7. Mura M, dos Santos CC, Stewart D, Liu M. Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol 2004;97:1605-17.
8. Medford AR, Keen LJ, Bidwell LJ, Millar AB. Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. Thorax 2005;60;244-8.
9. Dvorak HF. Angiogenesis: update 2005. J Thromb Haemost 2005;3:1835-42.
10. Gerber HP, Wu X, Yu L, Wiesmann C. Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies. Proc Natl Acad Sci USA 2007;104:3478-83.
11. Fehrenbach H. Development of the pulmonary surfactant system. Pneumologie 2007;61:488-9.
12. Abadie Y, Bregeon F, Papazian L, Lange F, Chailley-Heu B, Thomas P et al. Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur Respir J 2005;25:139-46.
13. Neufeld G, Kessler O, Herzog Y. The interaction of neuropilin-1 and neuropilin-2 with tyrosine-kinase receptors for VEGF. Adv Exp Med Biol 2002;515:81-90.
14. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med 1994;20:225-32.
15. Kaner RJ, Crystal RG. Compartmentalization of vascular endothelial growth factor to the epitelial surface of the human lung. Mol Med 2001;7:240-6.
16. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006;39:469-78.
17. Van der Flier M, van Leeuwen HJ, van Kessel KP, Kimpen JL, Hoepelman AI, Geelen SP. Plasma vascular endothelial growth factor in severe sepsis. Shock 2005;23:35-8.
18. Strieter RM, Gomperts BN, Keane MP. The role of CXC chemokines in pulmonary fibrosis J Clin Invest 2007;117:549-56.
19. Dobyns EL, Eells PL, Griebel JL, Abman SH. Elevated plasma endothelin-1 and cytokine levels in children with severe acute respiratory distress syndrome. J Pediatr 1999;135:246-9.
20. Thickett DR, Armstrong L, Christie SJ, Millar AB. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:1601-5.
21. Keane MP, Donnelly SC, Belperio JA, Goodman RB, Dy M, Burdick MD et al. Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome. J Immun 2002;169:6515-21.
22. Meduri GU, Eltorky M, Winer-Muram HT. The fibroproliferative phase of late adult respiratory distress syndrome. Semin Respir Infect 1995;10:154-75.
23. Su G, Hodnett M, Wu N, Atakilit A, Kosinski C, Godzich M et al. Integrin regulates lung vascular permeability and pulmonary endothelial barrier function. Am J Respir Cell Mol Biol 2007;36:377-86.
24. Van der Heijden M, Van Nieuw Amerongen GP, Koolwijk P, Van Hinsbergh VWM, Groeneveld J. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 2008;63:903-9.
25. Papaioannou AI. Kostikas K, Kollia P, Gourgoulianis. Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Resp Res 2006;7:128-41.
26. Perkins GD, Roberts J, McAuley DF, Armstrong L, Millar A, Gao F et al. Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury. Thorax 2005;60:153-8.
27. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and its receptor KDR/Flk-1 in smoking-induced emphysema. Am J Respir Crit Care Med 2001;163:737-44
28. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106:1311-9.
29. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003;29:88-97.
30. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H et al. Loss of HIF-2 and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002;8:702-10.
31. Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q et al. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 2000;106:783-91.
32. Partovian C, Adnot S, Raffestin B, Louzier V, Levame M, Mavier IM et al. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am J Respir Cell Mol Biol 2000;23:762-71.
33. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998;273:30336-43.
34. Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, Sessa WC. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 2001;276:30359-65.
35. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGFB and VEGF. Development 1998;125:1591-8.
36. Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, Carmeliet P et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 2002;21:1939-47.
37. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L et al. VEGF is required for growth and survival in neonatal mice. Development 1999;126:1149-59.
38. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-51
39. Kaner RJ, Ladetto JV, Singh R, Fukuda N, Matthay MA, Crystal RG. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol 2000;22:657-64.
40. Hoidal JR. Reactive oxygen species and cell signaling. Am J Respir Cell Mol Biol 2001;25:661-3.
41. Maitre B, Biussat S, Jean D, Gouge L, Brochard L, Housset B et al. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J 2001;18:100-6.
42. Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF. Endoglin (CD105) and vascular endothelial growth factor as a prognostic markers in colorectal cancer. Mod Pathol 2004;17:197-203.
43. Cebe-Suarez S, Zehnder-Fjallman A, Ballmer-Hofer K. The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol Life Sci 2006;63:601-15.
44. Barleon B, Reusch P, Totzke F. Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors. Angiogenesis 2001;4:143-54.
45. Akslen LA, Jacobsen GK, Vainio O. Angiogenesis - recent developments in molecular pathogenesis, morphological markers and therapeutic applications. APMIS 2004;112:399-401.
46. Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001;49:568-81.
47. Ohwada A, Yashioka Y, Iwabuki K, Nagaoka I, Dambara T, Fukuchi Y. VEGF regulates the proliferation of acid-exposed alveolar lining epithelial cells. Thorax 2003;58:328-32.
48. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108:2369-79
49. Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 2001;114:853-65.
50. Alom-Ruiz SP, Anilkumar N, Shah AM. Antioxidants & Redox Signaling 2008;10:1089-100.
51. Alavi A, Hood JD, Frausto R, Stupack DG, Cheresh DA. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 2003;301:94-6.
52. Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998;273:13313-6.
53. Kolmakova A, Rajesh M, Zang D, Pili R, Chatterjee S. VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo. Glycoconj J 2009;26:547-58.
54. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev 1999;10:27-39.